TE_77
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MER102b |
|---|---|
| TE superfamily | Charlie |
| TE class | DNA |
| Gene | RERE |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 1.52 |
| Counts of samples | TCGA_tumor:159; TCGA_normal:1; GTEx:117 |
| TSS | chr1(-):8499432 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_77.21 | RERE | Chimeric | Other | MPGVNDCDLLMYLRAARSMAAFAGMCDGGSTEDGCVAASRDDTTLNALNTLHESGYDAGKALQRLVKKPVPKLIEKCWTEDEVAGGPKTNKQKT* | chr1(-):8438280,8438300,8449197,8449267,8465925,8466023,8495063,8495162,8497405,8497492,8499403,8499433 |
| teRNA_77.22 | RERE | Chimeric | Non-coding | Non-coding | chr1(-):8466003,8466023,8495063,8495162,8497405,8497492,8499403,8499433 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
